Breast cancer chemoprevention in primary care: Assessing readiness for change.

Abstract

1547Background: Despite FDA approval of medications for breast cancer risk reduction and professional organizations’ (ASCO, USPSTF & NCCN) chemoprevention recommendations, chemoprevention use has not increased substantially. Barriers and facilitators to primary care providers’ (PCP) incorporation of breast cancer chemoprevention could inform efforts to increase uptake. Methods: We conducted an online survey of PCPs’ regarding awareness and use of breast cancer chemoprevention, and perceived barriers/solutions. All eligible PCPs at Geisinger Health System (family physicians, internists, residents, physician assistants, nurse practitioners) who practice ≥ one-half day per week in a family practice, internal medicine or OB-GYN outpatient clinic were invited to participate via email (four attempts total). Results: Of 492 invited providers, 195 (40%) participated (mean age 41 years, 61% female, 70% MD/DO, 45% ≥ 10 years in practice). Of the 195 participants, 74 (38%) used the Gail model for breast cancer risk ...